<DOC>
	<DOCNO>NCT00517257</DOCNO>
	<brief_summary>The ATORVO study design determine whether atorvastatin ( Lipitor ) improve vision , compare placebo</brief_summary>
	<brief_title>Atorvastatin Treatment Retinal Vein Occlusion</brief_title>
	<detailed_description>Retinal vein occlusion ( RVO ) , common cause visual loss Western world , disease whose etiology resemble classic atherosclerosis . A therapy lower risk arterial venous thrombosis would seem reasonable approach manage disease , currently treatment . ATORVO randomize double-masked clinical trial compare daily dose 80 mg atorvastatin match placebo person recently diagnose RVO . At 24 week randomization , evaluate participant 's visual acuity presence secondary complication relate RVO .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Adults age 40 year old Diagnosed CRVO BRVO Visual acuity 20/40 worse affect eye Onset current symptom loss vision within past 60 day Ability understand speak English Current use statin fibrate medication Known cardiovascular disease revascularization , include coronary artery disease ( myocardial infarction angina ) , stroke peripheral artery occlusion Known diabetes mellitus Known liver disease Serum lowdensity lipoprotein cholesterol ( LDLC ) &gt; 5.0 mmol/L Baseline serum triglyceride &gt; 6.0 mmol/L Serum ALT 115 U/L ( i.e. , 2.5 x upper limit normal ) Baseline serum creatinine &gt; 250 Âµmol/L Ocular surgery within past 90 day Planned ocular cataract surgery within study period Known retinal disease : agerelated macular degeneration , retinal detachment macular hole , past history vein occlusion Women pregnant breastfeed Participation another clinical trial concurrently within 30 day prior screen Known allergy fluorescein dye Current use cyclosporine medication . Current use HIV protease inhibitor medication .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Retinal vein occlusion</keyword>
	<keyword>Retinal vein thrombosis</keyword>
	<keyword>Central retinal vein occlusion</keyword>
	<keyword>Branch retinal vein occlusion</keyword>
	<keyword>Visual loss</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Statin</keyword>
	<keyword>Neovascularization</keyword>
	<keyword>Thrombosis</keyword>
</DOC>